LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Q1 2016 13F Holders as of 3/31/2016

Type / Class
Debt / NOTE 0.750% 8/1
Number of holders
22
Total Principal
246M
Shares change
+4M
Total reported value, excl. options
$373M
Value change
+$4.77M
Put/Call ratio
0
Number of buys
7
Number of sells
-12
Price
$1.52
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.